Thomson Reuters/Uni...
Health Care: Drugs
A.P. Pharma Inc. (APPA: OTC)
$0.46 -0.02 | -4.17%
05/17/13 - 03:58 PM ET
Portfolios with APPA
- Portfolio NameUser Type
- UserMy Folio
- Userwatchlist1
- UserMARK 1 C
- ContributorBarron's Insider Purchases ...
- UserSUPRATRADE-2709091838
- UserLatest Activist Filings 2-2...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
Latest APPA Headlines from TheStreet
- The Next Big Thing In Biotech: Decision Week
03.21.13 | 09:03 am - Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
- Biotech Stock Mailbag: Celsion, Navidea, AP Pharma, Sarepta 02.01.13 | 07:02 am
- A.P. Pharma Run-Up Trade Into FDA Approval Decision 01.22.13 | 08:01 am
- AP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up Trades 10.09.12 | 07:10 am
- Ambac Financial, QAD: Early Volume Plays 05.18.10 | 08:05 am
- A.P. Pharma, Netlist: Early Volume Plays 03.19.10 | 10:03 am
- Biotech Stock Mailbag: Sequenom 03.12.10 | 07:03 am
- Latest News in Activist Investing 02.26.09 | 11:02 am
Press Releases for APPA
- A.P. Pharma Receives FDA Complete Response Letter For APF530 - Business Wire 03.28.13 | 07:03 am
- A.P. Pharma Announces Fourth Quarter And Full Year 2012 Financial Results And Highlights Recent Corporate Progress - Business Wire 03.01.13 | 08:03 am
- A.P. Pharma Appoints Jesse Hollingsworth As Vice President Of Sales - Business Wire 02.28.13 | 08:02 am
- A.P. Pharma Names Mark S. Gelder, M.D. As Senior Vice President And Chief Medical Officer - Business Wire 12.13.12 | 08:12 am
- A.P. Pharma Announces Third Quarter 2012 Financial Results And Highlights Recent Corporate Progress - Business Wire 11.05.12 | 08:11 am
- A.P. Pharma Appoints Robert Rosen As Senior Vice President And Chief Commercial Officer - Business Wire 10.18.12 | 08:10 am
- A.P. Pharma Announces PDUFA Action Date For APF530 New Drug Application Resubmission - Business Wire 10.16.12 | 08:10 am
- A.P. Pharma Resubmits New Drug Application For APF530, A Product Candidate For The Prevention Of Chemotherapy-Induced Nausea And Vomiting - Business Wire 09.28.12 | 08:09 am
- A.P. Pharma Appoints Thomas Pitler, Ph.D. As Vice President Of Business Development - Business Wire 09.10.12 | 08:09 am
- A.P. Pharma Announces Second Quarter 2012 Financial Results And Highlights Recent Corporate Progress - Business Wire 08.02.12 | 08:08 am
Partner Headlines for APPA
- REVEALED: New Analyst Stock Coverage to Assess Today - Wall St. Cheat Sheet 06.13.12 | 04:06 am
- Mannkind Slashes Staff: Biotech's Latest Tribulations - Seeking Alpha 02.13.11 | 08:02 am
- UPDATE 3-FDA denies approval of AP Pharma nausea drug; shrs sink - Reuters 03.19.10 | 12:03 pm
